Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zevra Therapeutics

9.74
+0.33003.51%
Post-market: 9.740.00000.00%16:48 EDT
Volume:1.18M
Turnover:11.52M
Market Cap:532.58M
PE:-5.22
High:10.03
Open:9.41
Low:9.29
Close:9.41
Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Investar, Steel Dynamics, Axos Financial

Reuters
·
03 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Zevra Therapeutics, Abeona Therapeutics, Greenbrier

Reuters
·
02 Jul

BUZZ-Zevra Therapeutics rises after H.C. Wainwright starts coverage with 'buy' rating

Reuters
·
02 Jul

Zevra Therapeutics, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating

THOMSON REUTERS
·
02 Jul

Chief Legal & Compliance Officer Rahsaan Thompson Reports Disposal of Common Shares of Zevra Therapeutics Inc

Reuters
·
01 Jul

Press Release: Zevra Announces Final Results of 2025 Annual Meeting of Stockholders

Dow Jones
·
30 May

Zevra Therapeutics (ZVRA) Receives a Buy from Citizens JMP

TIPRANKS
·
27 May

BRIEF-Zevra Therapeutics ISS, Glass Lewis & Egan-Jones Recommend Zevra Stockholders Vote For Co's Director Nominees

Reuters
·
21 May

Zevra announces 3 proxy advisory firms recommended vote ‘FOR’ Dixon, Favorito

TIPRANKS
·
21 May

Zevra Therapeutics Price Target Maintained With a $25.00/Share by Cantor Fitzgerald

Dow Jones
·
14 May

Zevra Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Zevra Therapeutics Q1 Net Loss Narrows, Revenue Rises; Shares Gain After Hours

MT Newswires Live
·
14 May

Zevra Therapeutics reports Q1 EPS (6c), consensus (18c)

TIPRANKS
·
14 May

BRIEF-Zevra Therapeutics Q1 Operating Expenses USD 22.803 Million

Reuters
·
14 May

Zevra Therapeutics Q1 EPS $(0.06) Beats $(0.20) Estimate, Sales $20.40M Beat $16.96M Estimate

Benzinga
·
14 May

Press Release: Zevra Reports First Quarter 2025 Financial Results and Corporate Update

Dow Jones
·
14 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Zevra Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
10 May

Zevra Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
06 May

Zevra Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
03 May